HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 91 filers reported holding HARROW HEALTH INC in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $34,339 | -22.1% | 3,066 | 0.0% | 0.00% | -25.0% |
| Q3 2023 | $44,058 | -24.5% | 3,066 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $58,377 | -10.0% | 3,066 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $64,877 | +144071.1% | 3,066 | 0.0% | 0.01% | +50.0% |
| Q4 2022 | $45 | -99.9% | 3,066 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $37,000 | +68.2% | 3,066 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $22,000 | +4.8% | 3,066 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $21,000 | -19.2% | 3,066 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $26,000 | -7.1% | 3,066 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $28,000 | 0.0% | 3,066 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $28,000 | -26.3% | 3,066 | -44.8% | 0.00% | -25.0% |
| Q1 2021 | $38,000 | 0.0% | 5,556 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $38,000 | -11.6% | 5,556 | -28.2% | 0.00% | -20.0% |
| Q3 2020 | $43,000 | +7.5% | 7,736 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $40,000 | – | 7,736 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,710,000 | $14,119,000 | 2.85% |
| Diametric Capital, LP | 288,238 | $1,502,000 | 1.15% |
| Birchview Capital, LP | 180,000 | $938,000 | 0.57% |
| Sio Capital Management, LLC | 238,623 | $1,243,000 | 0.36% |
| CORRADO ADVISORS, LLC | 43,400 | $226,000 | 0.20% |
| CADENCE CAPITAL MANAGEMENT LLC | 241,450 | $1,258,000 | 0.18% |
| BARD ASSOCIATES INC | 287,250 | $1,495,000 | 0.17% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 195,876 | $1,021,000 | 0.06% |
| Uniplan Investment Counsel, Inc. | 151,305 | $788,000 | 0.06% |
| HighVista Strategies LLC | 10,300 | $54,000 | 0.04% |